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Abstract
Background: Highly pathogenic avian influenza (HPAI) H5N1 virus is entrenched in poultry in Asia
and Africa and continues to infect humans zoonotically causing acute respiratory disease syndrome
and death. There is evidence that the virus may sometimes spread beyond respiratory tract to
cause disseminated infection. The primary target cell for HPAI H5N1 virus in human lung is the
alveolar epithelial cell. Alveolar epithelium and its adjacent lung microvascular endothelium form
host barriers to the initiation of infection and dissemination of influenza H5N1 infection in humans.
These are polarized cells and the polarity of influenza virus entry and egress as well as the secretion
of cytokines and chemokines from the virus infected cells are likely to be central to the
pathogenesis of human H5N1 disease.
Aim: To study influenza A (H5N1) virus replication and host innate immune responses in polarized
primary human alveolar epithelial cells and lung microvascular endothelial cells and its relevance to
the pathogenesis of human H5N1 disease.
Methods: We use an in vitro model of polarized primary human alveolar epithelial cells and lung
microvascular endothelial cells grown in transwell culture inserts to compare infection with
influenza A subtype H1N1 and H5N1 viruses via the apical or basolateral surfaces.
Results: We demonstrate that both influenza H1N1 and H5N1 viruses efficiently infect alveolar
epithelial cells from both apical and basolateral surface of the epithelium but release of newly
formed virus is mainly from the apical side of the epithelium. In contrast, influenza H5N1 virus, but
not H1N1 virus, efficiently infected polarized microvascular endothelial cells from both apical and
basolateral aspects. This provides a mechanistic explanation for how H5N1 virus may infect the
lung from systemic circulation. Epidemiological evidence has implicated ingestion of virus-
contaminated foods as the source of infection in some instances and our data suggests that viremia,
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HPAI H5N1 virus was a more potent inducer of cytokines (e.g. IP-10, RANTES, IL-6) in comparison
to H1N1 virus in alveolar epithelial cells, and these virus-induced chemokines were secreted onto
both the apical and basolateral aspects of the polarized alveolar epithelium.
Conclusion: The predilection of viruses for different routes of entry and egress from the infected
cell is important in understanding the pathogenesis of influenza H5N1 infection and may help
unravel the pathogenesis of human H5N1 disease.
Introduction
Highly pathogenic influenza (HPAI) H5N1 virus first
emerged as a cause of severe human disease in 1997 in
Hong Kong [1,2]. Since then, it has become entrenched in
poultry across Asia and Africa with zoonotic transmission
to humans, sometimes with fatal outcome. In contrast to
human seasonal influenza, H5N1 disease has a higher
reported case-fatality rate ranging from 33% in Hong
Kong in 1997 to 61% more recently [1,3]. The reason for
this unusual severity of human disease remains unclear.
Within the lung, the alveolar epithelium is the primary
target cell for influenza H5N1 virus [4-6]. Although a
novel influenza H1N1 virus of swine origin has recently
emerged to cause a pandemic [7,8], the pathogenesis of
H5N1 virus remains an important public health issue
because this virus remains a pandemic and public health
threat, either directly or through reassortment with the
novel pandemic H1N1 virus.
Epithelial cells line the major cavities of the body, func-
tioning in selective secretion and adsorption, and provid-
ing a barrier to the external environment. In human lung,
the alveolar epithelium consists of a continuous layer of
tissue made up of two principal cell types: flattened type I
alveolar epithelial cells and cubodial type II alveolar epi-
thelial cells. Type I alveolar epithelial cells cover over 80%
of the alveolar surface in which they function as a broad
thin layer for gaseous exchange. These cells are highly
polarized since the plasma membranes of these cells are
divided into two discrete domains, namely, the apical
domain (facing the luminal air surface) and the basola-
teral domain (facing the systemic circulation) [9]. And
this large thin surface makes them extremely susceptible
to injury from inhaled pathogens. While there is some
data on H5N1 virus infection and cytokine responses in
alveolar epithelial cells [10], there is no information of
the effect of cell polarity on H5N1 virus replication or on
virus-induced host responses.
Though influenza virus infection is localized primarily to
the respiratory system, HPAI in some avian species is asso-
ciated with systemic dissemination of the virus to multi-
ple organs. There is increasing evidence that H5N1
influenza viruses are found in the peripheral blood, the
gastro-intestinal tract and occasionally even the central
nervous system of humans, and such dissemination may
contribute to unusual disease manifestations including
those of multiple organ dysfunction [11-14]. The close
anatomical relationship between alveolar epithelium and
the lung microvascular endothelium, together with the
distribution of putative influenza A virus receptors on the
endothelial cell surface [15], make it important that paral-
lel investigations on the lung epithelium and lung
endothelium are carried out.
In the present study, we investigated the infection of
polarized, primary, human type I-like alveolar epithelial
cells and lung microvascular endothelial cells by influ-
enza A virus. The low pathogenic human seasonal influ-
enza virus, A/HK/54/98 (H1N1) and the HPAI A/HK/
483/97 (H5N1) virus were studied. We found that both
influenza H1N1 and H5N1 viruses efficiently infect alve-
olar epithelial cells from both apical and basolateral sur-
face of the epithelium. Irrespective of the route of
infection, both viruses were preferentially released at the
apical surface of the alveolar epithelium. Whereas in lung
microvascular endothelial cells, influenza H1N1 virus
failed to replicate convincingly in contrast, influenza
H5N1 virus showed evidence of replication following
infection by either apical or basolateral route and new
virus was released from both sides of the cell. As previ-
ously reported [10], influenza H5N1 virus was a more
potent inducer of cytokines and chemokines (e.g. IP-10,
RANTES, IL-6) in comparison to H1N1 virus in alveolar
epithelial cells. Influenza H5N1 virus induced chemok-
ines were secreted on both the apical and basolateral
aspects of the polarized alveolar epithelium while the
human influenza H1N1 virus led predominantly to apical
secretion. These findings enhance the understanding of
how virus infection may spread within and beyond the
lung in influenza virus infection and how innate host
response may contribute to modulating or aggravating tis-
sue pathology.
Materials and methods
Isolation of primary human alveolar epithelial cells
Primary alveolar epithelial cells were isolated from
human non-tumor lung tissue obtained from patients
undergoing lung resection in the Department of Cardiot-
horacic Surgery, Queen Mary Hospital and Queen Eliza-Page 2 of 12
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by The Hong Kong University and Hospital Authority
(Hong Kong West and Kowloon Central/East, respec-
tively) Institutional Review Board, using a modification of
methods previously described [16]. Briefly, lung tissue
was minced into pieces of > 0.5 mm thickness using a tis-
sue chopper. The tissue was digested using a combination
of trypsin and elastase for 15 min at 37°C in a shaking
water-bath. The cell population was purified by a combi-
nation of differentiated cell attachment, Percoll density
gradient centrifugation and magnetic cell sorting. The
cells were maintained in a humidified atmosphere (5%
CO2, 37°C) under liquid-covered conditions, and growth
medium was changed daily starting from 60 h after plat-
ing the cells.
Type I-like alveolar epithelial cell differentiation and 
polarization
The purified cell pellet (passage 1 or 2) was resuspended
in medium to a final concentration that allowed seeding
at 5 × 105 cells/cm2 onto collagen I coated Transwell sup-
ports (Corning) and cultured for 14 to 20 days with the
small airway culture medium SAGM (Lonza) in the apical
and basolateral chambers of the Transwell. The cells
spread to form a confluent monolayer and the culture
medium was changed every 48 h. A concomitant increase
in transepithelial electrical resistance (TER) was measured
using an epithelial tissue voltohmmeter (EVOM). TER was
calculated as the measured electrical resistance (Ohms)
multiplied by the surface area of the filter. This method
has already been established in our laboratory using a
modification of the methods previously described
[16,17]. When the transepithelial electrial resistance
(TEER) reached 1000 ohm cm2, which demonstrate the
paracellular restrictiveness of the alveolar cell preparation,
the competence of the formation of tight junctional com-
plexes within the polarized alveolar epithelial cells model
can be assessed [16] and the cells were used for virus infec-
tion experiments.
Culture and polarization of lung microvascular endothelial 
cell
Primary human lung microvascular endothelial cells
(HLMVE) were purchased from Lonza Walkersville, Inc.
(US) and maintained in the medium and growth supple-
ments supplied by the manufacturer (EGM-2), which con-
tained 5% fetal bovine serum (FBS), hydrocortisone,
human endothelial growth factor, vascular endothelial
cell growth factor, human fibroblast growth factor basic,
long(R3)-insulin-like growth factor-1, ascorbic acid and
antibiotics. Medium was changed every 48 h until conflu-
ence. The HLMVE were seeded in the apical compartment
of a 0.4 μm pore size transwell support (Corning) with a
cell density of 5 × 105 cells/cm2. The cells were cultured for
10 days with medium changed in both the apical and
basolateral compartments every 48 h. When the transepi-
thelial electrial resistance (TEER) reached 25 ohm cm2,
the cells were used for virus infection experiment [18].
Viruses
We used HPAI H5N1 virus (A/Hong Kong/483/97), a
virus isolated from a patient with fatal influenza H5N1
disease in Hong Kong in 1997, and A/Hong Kong/54/98
(H1N1) as a representative seasonal influenza virus, for
our comparative studies. Viruses were initially isolated
and subsequently maintained in Madin-Darby canine kid-
ney (MDCK) cells. They were cloned by limiting dilution
and seed virus stocks were prepared in MDCK cells. Virus
infectivity was assessed by titration of tissue culture infec-
tion dose 50% (TCID50) in MDCK cells. The influenza
H5N1 virus used in this study was handled in a Bio-safety
level 3 (BSL-3) facilities in the Department of Microbiol-
ogy, The University of Hong Kong.
Virus infection of cells
Virus inoculation procedures were designed to determine
the role of cell polarity in direction of infection, virus
release and cytokine secretion. Polarized type I-like alveo-
lar epithelial cells and HLMVE were seeded on the apical
surface of the transwell membrane and infected from the
apical or basolateral surface respectively. During apical
infection, 200 μl of virus was added into the apical com-
partment of the transwell (Figure 1A) while during baso-
lateral infection, 80 μl of virus was added onto the
transwell membrane with the transwell oriented upside
down (Figure 1B). The orientation of the transwell in the
apical infection situation was resumed at 1 h after virus
inoculation and the washing steps. In this series of exper-
iments, we used a MOI of 0.01 to evaluate the difference
between the two routes of infection in terms of release of
Representation of the transwell insert-setup during the influ-enza virus infection experimentFigure 1
Representation of the transwell insert-setup during 
the influenza virus infection experiment. Type I-like 
alveolar epithelial cells or HLMVEs (indicated in blue) were 
seeded on top of the porous membrane. During apical infec-
tion (A) virus was added into the apical compartment while 
the transwell was placed upside down during basolateral 
infection (B).
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centage of cell infection and cytokine release.
Virus replication analysis
Evidence of viral infection was established by a) assaying
viral matrix RNA at 1, 3, 6 and 24 h post infection by
quantitative RT-PCR, b) viral antigen expression by
immunofluorescence staining with mouse anti-influenza
nucleoprotein and matrix antibody conjugated with FITC
(DAKO Imagen, Dako Diagnostics Ltd, Ely, UK) and c)
assaying infectious virus in cell culture supernatant by
TCID50 assay to demonstrate complete virus replication.
Quantification of cytokine and chemokine mRNA by real-
time quantitative RT-PCR
DNase-treated mRNA from infected cells model was
extracted at 1, 3, 6 and 24 h post infection using RNeasy
Mini kit (Qiagen, Hilden, Germany). The cDNA was syn-
thesized from mRNA with Oligo-dT primers and Super-
script III reverse transcriptase (Invitrogen) and quantified
by real-time quantitative PCR analysis with a LightCycler
(Roche, Mannheim, Germany). The gene expression pro-
file for cytokines (interferon beta (IFN-β), IL-6) and
chemokines (IP-10, RANTES) and viral matrix gene were
quantified and normalized using the housekeeping gene
product β-actin mRNA.
Quantification of cytokine and chemokine proteins by 
ELISA
The concentrations of IP-10, RANTES, IL-6 and IFN-β pro-
teins in the influenza virus infected type I-like alveolar
epithelial cells were measured by a specific ELISA assay
(R&D Systems, Minneapolis, MN, USA). Samples of cul-
ture supernatant were irradiated with ultraviolet light (CL-
100 Ultra Violet Cross linker) for 15 min to inactivate any
infectious virus before the ELISA assays were done. Previ-
ous experiments had confirmed that the dose of ultravio-
let light used did not affect cytokine concentration as
measured by ELISA (data not shown).
Lectin histochemistry
Type I-like alveolar epithelial cells cultured in transwell
insert and HLMVE cell pellet were fixed with 10% forma-
lin and sectioned at 5 μm followed by lectin histochemis-
try as published previously [19]. The cells were
microwaved in 10 mM citrate buffer pH 6.0 at 95 °C for
15 min then blocked with 3% H2O2 in TBS for 12 min and
with avidin/biotin blocking kit (Vector). They were then
incubated with 1:100 HRP conjugated Sambucus nigra
agglutinin (SNA) (EY Laboratories), 1:100 biotinylated
MAL-I and MAL-II (Vector) and Digoxigenin conjugated
MAA (Roche) for 1 h at room temperature (RT), blocked
with 1% bovine serum albumin for 10 min at RT, and
then incubated with strep-ABC complex (Dako Cytoma-
tion, K-0377) diluted 1:100 for 30 min at RT. Develop-
ment was performed using the AEC substrate kit (Vector)
at RT for 10 min, the nuclei were counterstained with
Mayer's hematoxylin and then the sections were dried and
mounted with DAKO aqueous mount (Dako Cytoma-
tion). Duck intestine sections were used as controls with
and without pre-treatment with sialic acid (Sia) α2-3 spe-
cific neuraminidase from Glyko to ensure that Sias were
specifically targeted.
Statistical analysis
Two-tailed student t-test was used to compare the differ-
ent of viral titers in the influenza virus infected cell super-
natants between the early and late time point. The
quantitative cytokine and chemokine mRNA and protein
expression profile of mock, influenza H1N1 and H5N1
virus infected cells were compared using one-way
ANOVA, followed by Bonferroni multiple-comparison
test. Differences were considered significant at p < 0.05.
Results
Sialic acid receptor distribution on the polarized type I-like 
alveolar epithelial cell and HLMVE
Lectin histochemistry on the primary culture of human
type I-like alveolar epithelial cells using SNA and MAA
showed that MALII (which recognizes the accepted avian
influenza receptor Siaa2-3Galβ1-3GalNAc) bound
strongly to the type I-like alveolar epithelial cells (Figure
2A-2D). Staining with SNA which recognizes the human
influenza receptor Siaα2-6 in type I-like alveolar epithelial
cells was not prominent on the type I-like alveolar epithe-
lial cells, results that are similar to the report by Shinya et
al [5]. The lectin histochemistry on the HLMVE cells
shows binding of both SNA (Figure 2E) and MALII (Figure
2F) which agrees with previous reports [15].
Polarity of influenza A virus infection and replication in 
alveolar epithelial cells
Both influenza A viruses, A/HK/54/98 (H1N1) and A/HK/
483/97 (H5N1) were able to infect the type I-like alveolar
epithelial cells from both the apical and basolateral com-
partments. The influenza matrix gene expression
increased from 3 h to 24 h post infection (p < 0.05). Apical
infection resulted in greater matrix gene copy number at 3
h post infection compared with basolateral infection of
type I-like alveolar epithelial cells with A/HK/54/98
(H1N1) but these differences were less marked at 6 h and
24 h post infection. The matrix gene copy number in type
I-like alveolar epithelial cells infected with influenza A/
HK/483/97 (H5N1) virus apically was higher than that of
cells infected via the basolateral aspect at all three time
points, 3 h, 6 h and 24 h post infection (Figure 3).
Viral protein expression was detected by immunofluores-
ence in both influenza A/HK/54/98 (H1N1) and A/HK/
483/97 (H5N1) virus infected alveolar epithelial cells,Page 4 of 12
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of cells infected was significantly higher (p = 0.02 and p =
0.01) in influenza A/HK/54/98 (H1N1) and A/HK/483/
97 (H5N1) virus, respectively when the virus was inocu-
lated from the apical than from the basolateral side (Fig-
ure 4).
TCID50 assay was performed on the supernatant collected
from the infected type I-like alveolar epithelial cells
infected with highly pathogenic influenza H5N1 (A/HK/
483/97) or low pathogenic human influenza H1N1 (A/
HK/54/98) viruses to determine the infectious virus yield.
Regardless of the infection route and virus strain, increas-
ing TCID50 titers were observed in supernatants collected
from the apical compartment but not from the basolateral
compartment (Figure 5, legend Ab and Bb) (Figure 5).
Release of newly formed virus from type I-like alveolar
epithelial cells infected via the apical or basolateral sur-
face by either influenza H1N1 or H5N1 viruses was
restricted to the apical side of the cells (Figure 5A and 5B).
Following basolateral infection, the titers of virus shed on
the apical aspect of the cell was higher (p = 0.017) follow-
ing influenza H5N1 virus infection rather than influenza
H1N1 virus infection (Figure 5C).
Polarity of influenza virus infection and replication in lung 
microvascular endothelial cell
In order to better understand the implications of the
effects of cell polarity on virus infection in relation to virus
dissemination via the systemic circulation, we investi-
gated the replication of influenza H5N1 and H1N1
viruses in polarized HLMVE cells. There was no convinc-
ing evidence of influenza H1N1 virus replication when
HLMVE cells were infected via either the apical or basola-
teral aspect (Figure 6A). Interestingly, HLMVE cells
infected with influenza H5N1 virus via either apical or
Lectin binding assay to determine the Sias distribution on polarized type I-like alveolar epithelial cells and HLMVEsFigure 2
Lectin binding assay to determine the Sias distribution on polarized type I-like alveolar epithelial cells and 
HLMVEs. (A, C, E) SNA binds to Siaa2-6Gal and (B, D, F) MAA binds to Siaa2-3Gal presented on the (A-D) type I-like alveo-
lar epithelial cells and (E-F) HLMVE cell pellet in reddish brown. En face sections were generated from selected planes in the 
vertical sections.Page 5 of 12
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cal and basolateral aspects of the cell (p < 0.05) (Figure
6B).
Expression of cytokine and chemokine in type I-like 
alveolar epithelial cell infected with influenza virus 
through apical and basolateral routes
We next investigated the effects of cell polarity on cytokine
and chemokine induction by influenza H1N1 and H5N1
virus infected primary human type I-like alveolar epithe-
lial cells. Specifically, we wanted to determine whether the
apical and basolateral infection route led to qualitative or
quantitative differences in the profile of cytokines
induced. The efficiency of infection of the cells by the api-
cal route was 70-100% and basolateral route was 30-50%.
As previously reported by us, there was a trend that influ-
enza H5N1 virus infection led to increased levels of
cytokine mRNA at 24 h post infection when compared
with influenza H1N1 virus, irrespective of whether such
infection occurred by the apical (black bars) or basolateral
(grey bars) aspect (Figure 7). The differences between
influenza H5N1 and H1N1 viruses achieved statistical sig-
nificance with IFN β following apical (p < 0.05) and baso-
lateral (p < 0.01) infection (Figure 7A), IL-6 following
apical infection (p < 0.01) (Figure 7B), and IP-10 follow-
ing basolateral infection (p < 0.05) (Figure 7D). While
there was a trend suggesting that the chemokine gene
RANTES was hyper-induced by influenza H5N1 virus
when compared to that in influenza H1N1 virus, statisti-
cal significance was not achieved (p = 0.08 in apical infec-
tion and p = 0.14 in basolateral infection (Figure 7C).
Similar cytokine and chemokine expression profiles were
observed at 3 h and 6 h post infection in influenza virus
infected type I-like alveolar epithelial cells (data not
shown). Inactivation of the virus by ultraviolet irradiation
prior to infection of the type I-like alveolar epithelial cells
abolished cytokine induction (data not shown) suggest-
ing that virus replication was required for cytokine induc-
tion. Furthermore, even an increase in the MOI of
influenza H1N1 virus up to 5 did not result in the
cytokine mRNA expression level to levels similar to those
induced by influenza H5N1 virus (data not shown).
Broadly, the data from the apical infection are consistent
with our previous finding the differential induction of
proinflammatory cytokine by influenza H5N1 virus in
alveolar epithelial cells [10]. We now have thus confirmed
that these differences also apply in polarized alveolar epi-
thelium following infection via the basolateral aspect.
Polarity of cytokine secretion in influenza H5N1 virus 
infected alveolar epithelium
We next investigated whether there was polarity in the
secretion of cytokine proteins from type I-like alveolar
epithelial cells infected by influenza H1N1 and H5N1
viruses. The concentrations of the IP-10, RANTES and IFN
β were measured by ELISA in apical and basolateral cul-
ture supernatants of type I-like alveolar epithelial cells
infected by the apical route. In parallel with the gene
expression profile, influenza H5N1 virus elicited more
chemokine release in type I-like alveolar epithelial cells
than influenza H1N1 virus, at 24 h post infection. Influ-
enza H5N1 virus induced IP-10 protein secretion was
found on the apical side of the polarized type I-like alveo-
lar epithelial cells. This level was significantly higher than
the mock infected cells (p < 0.01) and influenza H1N1
virus infected cells (p < 0.05). In addition, a significantly
more IP-10 was secreted from the basolateral side of the
influenza H5N1 virus infected alveolar epithelial cells
when compared to mock and influenza H1N1 virus
infected cells (p < 0.05). In contrast, RANTES appeared
only to be secreted on the apical aspect of influenza H5N1
virus infected type I-like alveolar epithelial cells although
these results did not achieve statistical significance (Figure
8A). We failed to detect any IFN β proteins in the superna-
tant of type I-like alveolar epithelial cells after influenza
virus infection (data no shown) but it should be noted
that the limit of detection of the IFN β ELISA was high
(250 pg/ml) and this lack of sensitivity of the assay is
likely to be responsible for this lack of detection.
Viral matrix (M) gene expression in copy number normalized with β- ct n gene expression (105 copies) during i fection of human primary type I-like alve lar epithelial cellF gure 3
Viral matrix (M) gene expression in copy number 
normalized with β-actin gene expression (105 copies) 
during infection of human primary type I-like alveo-
lar epithelial cell. M gene expression in type I-like alveolar 
epithelial cells infected (MOI = 2) with influenza (A) A/HK/
54/98 (H1N1) and (B) A/HK/483/97 (H5N1) virus. Black cir-
cles indicate gene expression after apical infection and open 
square indicates gene expression after basolateral infection. 
Asterisk indicates a greater M gene expression in apical 
infected cells than basolateral infected cells with statistical 
significance of p < 0.05.Page 6 of 12
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In this study, we compared human influenza H1N1 virus
with a highly pathogenic influenza H5N1 virus to investi-
gate whether there are differences in the polarity of virus
infection and of host cytokine responses in human polar-
ized type I-like alveolar epithelium. The basolateral aspect
of the alveolar epithelium lies in close proximity to the
basolateral aspect of the lung microvascular endothelial
cells raising the question of whether virus regressing the
basolateral aspect of the type I-like alveolar epithelial cells
can infect the lung microvascular endothelial cells by the
basolateral aspect. Alternatively, since influenza H5N1
virus is believed to disseminate systemically and has been
detected in the peripheral circulation, it is relevant to
understand whether endothelial cells can be infected via
the apical aspect, thereby allowing virus in the blood cir-
culation to infect these cells and traffic outward to infect
the lung alveolar epithelium from the basolateral aspect.
As the lung endothelium covers about 20% of the total
surface area of the alveoli sac, the rest being covered by the
alveolar epithelium [20], the tropism of influenza A virus
in both alveolar epithelium and endothelium is impor-
tant in the pathogenesis of influenza H5N1 virus infection
in human.
Previously, the polarity of influenza virus infection and
release have only been studied with low pathogenic influ-
enza A virus (subtype H3N2) and low pathogenic avian
influenza A virus (subtype H5N3 and H4N6) [21] in
human airway trachea-bronchial epithelial cells. It was
demonstrated that newly forming influenza virus was
released from the apical surface of respiratory epithelium
[21,22]. However, the mouse-adapted influenza H1N1
virus (WSN strain) and Sendi virus have been shown to
bud from the apical and basolateral domains [23,24]. Ves-
ticular stomatitis virus and retroviruses [25] are released
from the basolateral domain of polarized cells, the sym-
metrical or asymmetrical binding, internalization and
budding of virus from polarized epithelial cells in culture
therefore would have potential implications for viral
pathogenesis. For example, with coronavirus, the apical
release of transmissible gastroenteritis virus resulted in a
local infection in vivo while the basolateral release of
mouse hepatitis virus (MHV) in epithelial cells resulted in
A representative immunofluorescence staining of type I-like alveolar epithelial cells after (A, D) mock, (B, E) influenza H1N1 and (C, F) H5N1 virus infection and (G) chart with rcentage of infectionFigure 4
A representative immunofluorescence staining of type I-like alveolar epithelial cells after (A, D) mock, (B, E) 
influenza H1N1 and (C, F) H5N1 virus infection and (G) chart with percentage of infection. Virus matrix protein 
and nucleoprotein were stained green by FITC-conjugated mouse antibody. The immunofluoresecent staining of the type I-like 
alveolar epithelial cells after apical (A-C) and basolateral (D-F) infection at 24 h post infection respectively. (G) Bar chart shows 
the mean percentage of infection and error bar represent the standard derivation, dark bar represents apical infection and 
open bar represents basolateral infection. Single and double asterisk indicates statistically significant difference with p < 0.05 
and p < 0.01 respectively.Page 7 of 12
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replicates in the nasal epithelium before being dissemi-
nated throughout the body. The basolateral release of
MHV from epithelial cells into the animal's circulation
was postulated as the first step in the establishment of a
systemic infection.
We showed that both influenza H1N1 and H5N1 viruses
preferentially infect type I-like alveolar epithelial cell from
its apical surface with higher levels of viral M gene expres-
sion as well as higher percentages of cells being infected,
when compared to basolateral infection (Figure 3 and 4).
This is expected since respiratory viruses need to be
adapted to efficiently infect cells via the apical surface,
which is the surface that is exposed to the respiratory
Virus titer detected in the supernatant of influenza virus infected type I-like alveolar epithelial cellsF gure 5
Virus titer detected in the supernatant of influenza virus infected type I-like alveolar epithelial cells. Virus titer 
of the (A) A/HK/54/98 (H1N1) and (B) A/HK/483/97 (H5N1) was determined after apical infection and basolateral infection of 
the type I-like alveolar epithelial cells at 3 h and 24 h post infection. Aa = apical release after apical infection, Ab = basolateral 
release after apical infection, Ba = apical release after basolateral infection, Bb = basolateral release after basolateral infection. 
(C) At 24 h post infection following basolateral infection of type I-like alveolar epithelial cells, the titers of influenza H5N1 virus 
at the apical aspect of the cells is significantly more seen with H1N1 infected cells. Single and double asterisk indicates statisti-
cally significant difference with p < 0.05 and p < 0.01, respectively. Dotted line represents the lowest detection limit of the 
TCID50 assay.
Virus titer detected in the supernatant of influenza virus infected HLMVE cellsF gure 6
Virus titer detected in the supernatant of influenza virus infected HLMVE cells. Virus titer of the (A) A/HK/54/98 
(H1N1) and (B) A/HK/483/97 (H5N1) was determined after apical infection and basolateral infection of the HLMVE cells at 1 h 
and 8 h post infection. Aa = apical release after apical infection, Ab = basolateral release after apical infection, Ba = apical 
release after basolateral infection, Bb = basolateral release after basolateral infection. Single and double asterisk indicates statis-
tically significant difference with p < 0.05 and p < 0.01 respectively. Dotted line represents the lowest detection limit of the 
TCID50 assay.Page 8 of 12
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enza H1N1 virus, release of newly formed virus was
restricted to the apical aspect, irrespective of whether the
alveolar epithelial cells were infected by the apical or
basolateral route (Figure 5). Again this is expected with a
virus that appears not to disseminate beyond the lung.
Similar observations have been reported in parainfluenza
virus infected epithelia with the virus preferentially enter-
ing and exiting via the apical surface [27,28]. Given its
propensity to disseminate beyond the lung, we initially
hypothesized that influenza H5N1 virus may be released
from both apical and basolateral aspects. But this proved
not to be the case and H5N1 was similar to H1N1 in this
respect, i.e. virus was released predominantly via the api-
cal aspect, irrespective of the route of infection of the cell
(Figure 5B). While the efficiency of infection via the baso-
lateral aspect was lower than that from the apical aspect
for both viruses, cells infected with H5N1 virus via the
basolateral aspect resulted in a greater than 10 fold higher
virus yields on the apical surface than cells comparably
infected with H1N1.
We then investigated virus replication in polarized lung
microvascular endothelium which is anatomically in
close proximity to the alveolar epithelium. There was no
convincing evidence of replication of H1N1 virus in the
polarized HLMVE cells (Figure 6A). In contrast, H5N1
virus could initiate productive replication of these cells
from either aspect and virus release also occurred from
apical or basolateral aspect of the cell (Figure 6B).
Although neither influenza H5N1 nor H1N1 viruses are
efficiently released via the basolateral aspect of the alveo-
lar epithelium, virus replication is likely to lead to weak-
ening of the tight-junctions and to cell death, thus
providing these viruses access to the underlying tissues
and the basolateral aspect of microvascular endothelial
cells. As the lung microvascular endothelium also com-
prises 20% of the total surface area of the alveoli [20],
Cytokine and chemokine gene expression in type I-like alveolar epithelial cells after influenza virus infectionFigure 7
Cytokine and chemokine gene expression in type I-like alveolar epithelial cells after influenza virus infection. 
The cytokine (A) IFN-β, (B) IL-6 and chemokine (C) RANTES, (D) IP-10 gene expression from type I-like alveolar epithelial cell 
after apical (black) and basolateral (grey) influenza A virus infection at 24 h post infection. The graph shows the mean and the 
standard error from three representative experiments. Single and double asterisk indicates statistically significant difference 
with p < 0.05 and p < 0.005 respectively.Page 9 of 12
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cells, replication within them and release from the apical
aspect of these cells could lead to viremia and dissemina-
tion of infection. The fact that HPAI H5N1 virus H0 pre-
cursor form can be cleaved by proteases not restricted to
the lung [29] facilitates disseminated virus infection.
The fact that influenza H5N1 (but not H1N1) virus can
infect the HLMVE cells from the basolateral aspect would
facilitate dissemination of this virus via the blood stream.
Furthermore, the observation that HLMVE cells can be
infected via the apical aspect and release virus from the
basolateral aspect (as well as the apical side) suggests that
systemically circulating virus can initiate infection in the
lung parenchyma via the endothelial route. This is partic-
ularly relevant since recent studies in mice have shown
that HPAI H5N1 virus experimentally injected into mus-
cle can led to fatal virus infection with virus establishing
infection in the lungs and brain [30]. Furthermore, there
has been speculation and anecdotal evidence that H5N1
virus can initiate infection via ingestion and the gastroin-
testinal tract [31]. The possibility that virus in the systemic
circulation can establish a foothold in the lung is therefore
an important observation.
Infected type I alveolar epithelial cells undergo either
cytolytic or apoptotic death. The shedding of infected type
I alveolar epithelial cells may further the inflammation
and the underlining interstitial cells may then be exposed
to the alveolar lumen fluid which contains high concen-
trations of virus. Reconstitution of the alveolar epithelial
surface depends on the regeneration type I alveolar epi-
thelial cell from its progenitor - the type II alveolar epithe-
lial cells [32]. However, an intact basement membrane is
essential for epithelial cell proliferation to occur. Alveolar
basement membrane with denuded alveolar epithelial
cell will accelerate the epithelial proliferation until the
epithelial layer becomes confluent [33]. Nevertheless,
type II alveolar epithelial cells could dominate the epithe-
lial surface and prevent the reappearance of type I alveolar
epithelial cell when injury signal of type I alveolar epithe-
lial cells persists in the microenvironment [34].
Previous reports on human lung epithelial cell line A549
infected with human influenza H3N2 virus showed a low
production of interferons and TNF-α [35]. We have previ-
ously shown, compared with influenza H1N1 virus, influ-
enza H5N1 virus differentially upregulated cytokine and
chemokine gene expression in alveolar epithelial cells
[10] and macrophages [36]in vitro experiments and that
the profile of differentially upregulated cytokines corre-
sponds with the elevated IP-10 and MIG levels of H5N1
patients serum [37]. Interestingly, IP-10 and MIG have
been reported to play roles in the pathogenesis of tissue
necrosis and vascular damage associated with certain EBV-
positive lymphoproliferative processes [38]. These results
again may dictate the different pathogenesis of the down-
stream cytokine and chemokine response events and con-
tribute to the unusual adverse pathology in H5N1 patient.
This study is the first demonstration of polarity secretion
of cytokines in influenza H5N1 infected alveolar epithe-
lium. The secretion of chemokines, notably IP-10, from
both the apical and basolateral aspect, was found in influ-
enza H5N1 virus infected type I-like alveolar epithelial
cell but not in influenza H1N1 virus infected cell. This
could potentially be relevant to the pathogenesis of influ-
enza H5N1 virus infected patients. The basolateral release
of chemotactic IP-10 from the influenza virus infected
type I-like alveolar epithelial cells recruit lymphocytes
Chemokine secretion from type I-like alveolar epithelial cells after influenza virus infectionFigure 8
Chemokine secretion from type I-like alveolar epithelial cells after influenza virus infection. The apical (dark bar) 
and basolateral release (grey bar) of (A) RANTES and (B) IP-10 protein from type I-like alveolar epithelial cell after apical infec-
tion of A/HK/54/98 (H1N1) and A/HK/483/97 (H5N1). Single asterisk indicates statistically significant difference with p < 0.05.Page 10 of 12
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chemokines to the receptor of the recruiting leukocytes is
specific and leads to a rapid change in the cell shape and
behavior of the subpopulation of the leukocyte. This
makes them capable of migrating from the blood through
the vascular endothelium into the site of inflammation
[39,40]. Previous studies on IP-10 and transendothelial
migration indicated that IP-10 retained on endothelial
cells could induce transendothelial chemotaxis of acti-
vated T cells [41]. Another investigation on the biological
activity of human recombinant IP-10 investigation further
verified its chemotactic properties towards human periph-
eral blood monocytes and stimulated human peripheral
blood T lymphocytes, but not neutrophils [42,43]. One of
the studies used endothelial cell adhesion assay to dem-
onstrate the effect of IP-10 in potentiating T cell adhesion
to endothelium [43]. The potent secretion of IP-10 from
both apical and basolateral side of the infected alveolar
type I-like alveolar epithelial cell that we observed would
suggest a possible directional recruitment and hence,
migration of T cells and monocytes from the lung blood
capillaries through microvascular transendothelial migra-
tion. Thus macrophages, differentiated from the recruited
monocytes, may dominate the alveolar space [13,17,37]
and T lymphocytes may occupy the interstitial space
[13,17,37,44,45] as previously documented in autopsy
reports of patients dying with influenza H5N1 virus infec-
tion. As cytokine secreting macrophages accumulate
within the alveoli, further augmentation of the cytokine
and chemokine cascades may result. Since influenza
H5N1 virus is reportedly resistant to the anti-viral effects
of interferons and TNF-α [46] and can lead to delayed
apoptosis of infected macrophages [47], the clearance of
the virus and lung inflammation would take a longer
period of time than with seasonal influenza infection.
Such prolonged inflammation would eventually result in
pathological features with diffuse alveolar damage, hem-
orrhage [48] and finally interstitial fibrosis [13,45,49,50],
which are some key observations in the H5N1 patients.
Conclusion
In this study, we demonstrate that both influenza H1N1
and H5N1 viruses efficiently infect alveolar epithelial cells
from both apical and basolateral surface of the epithelium
but release of newly formed virus is mainly from the api-
cal side of the epithelium. In contrast, influenza H5N1
virus, but not influenza H1N1 virus, efficiently infected
polarized lung microvascular endothelial cells from either
apical or basolateral aspect and also be released from
either aspect of these polarized cells. This is likely to be of
relevance to the pathogenesis and provides a possible
explanation for the entry to the respiratory tract via the
blood stream, as proposed by some who suggest that the
gastro-intestinal tract can be a portal of entry for this virus.
In addition, the release of inflammatory mediators such
as IP-10 may be important contributors to the pathogen-
esis of the disease. More detailed studies on the mecha-
nisms of alveolar epithelial cell damage and regeneration
and the mediators involved in this process will be impor-
tant in understanding the pathogenesis of human H5N1
disease.
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
MCWC, RWYC and JSMP conceived the study, planned
the overall experimental design and wrote the manuscript.
MCWC and RWYC carried out the experiments and inter-
pretation of results; CLY, CCH and KMY carried out exper-
iments in the BSL-2 laboratory and assisted in
experiments in the BSL-3 laboratory. WHC and CKL pro-
vided the lung biopsy specimens and JMN developed the
methods of immunohistochemistry and lectin staining
and YG critically reviewed the manuscript.
Acknowledgements
We are grateful for the help of Joanne HM Fong, Lynsia LS Tang and Tho-
mas YO Chan with the cell culture, and molecular biology analysis, Mr. 
Kevin Fung for the immunohistochemistry. This work was supported by 
Research Fund for Control of Infectious Disease Grant (RFCID grant, ref-
erence no: 03040712 and 06060552) from the Research Fund for Control 
of Infectious Disease, Health, Welfare and Food Bureau, Hong Kong SAR 
Government and the General Research Fund (HKU 761009M), Research 
Grants Council, Hong Kong SAR Government (to M.C.W.C); and AoE 
Funding (AoE/M-12/06) from the Area of Excellence Scheme of the Univer-
sity Grants Committee, Hong Kong SAR Government.
References
1. Claas EC, de Jong JC, van Beek R, Rimmelzwaan GF, Osterhaus AD:
Human influenza virus A/HongKong/156/97 (H5N1) infec-
tion.  Vaccine 1998, 16(9-10):977-978.
2. Yuen KY, Chan PK, Peiris M, Tsang DN, Que TL, Shortridge KF, Che-
ung PT, To WK, Ho ET, Sung R, et al.: Clinical features and rapid
viral diagnosis of human disease associated with avian influ-
enza A H5N1 virus.  Lancet 1998, 351(9101):467-471.
3. Cumulative Number of Confirmed Human Cases of Avian
Influenza A/(H5N1) Reported to WHO   [http://www.who.int/
csr/disease/avian_influenza/country/en/]
4. Nicholls JM, Chan MC, Chan WY, Wong HK, Cheung CY, Kwong DL,
Wong MP, Chui WH, Poon LL, Tsao SW, et al.: Tropism of avian
influenza A (H5N1) in the upper and lower respiratory tract.
Nat Med 2007, 13(2):147-149.
5. Shinya K, Ebina M, Yamada S, Ono M, Kasai N, Kawaoka Y: Avian flu:
influenza virus receptors in the human airway.  Nature 2006,
440(7083):435-436.
6. Uiprasertkul M, Puthavathana P, Sangsiriwut K, Pooruk P, Srisook K,
Peiris M, Nicholls JM, Chokephaibulkit K, Vanprapar N, Auewarakul
P: Influenza A H5N1 replication sites in humans.  Emerg Infect
Dis 2005, 11(7):1036-1041.
7. Emergence of a Novel Swine-Origin Influenza A
(H1N1)Virus in Humans.  N Engl J Med 2009.
8. Smith GJ, Vijaykrishna D, Bahl J, Lycett SJ, Worobey M, Pybus OG, Ma
SK, Cheung CL, Raghwani J, Bhatt S, et al.: Origins and evolution-
ary genomics of the 2009 swine-origin H1N1 influenza A epi-
demic.  Nature 2009, 459(7250):1122-1125.
9. Gstraunthaler GJ: Epithelial cells in tissue culture.  Ren Physiol Bio-
chem 1988, 11(1-2):1-42.
10. Chan MC, Cheung CY, Chui WH, Tsao SW, Nicholls JM, Chan YO,
Chan RW, Long HT, Poon LL, Guan Y, et al.: ProinflammatoryPage 11 of 12
(page number not for citation purposes)
Respiratory Research 2009, 10:102 http://respiratory-research.com/content/10/1/102cytokine responses induced by influenza A (H5N1) viruses in
primary human alveolar and bronchial epithelial cells.  Respir
Res 2005, 6:135.
11. Buchy P, Mardy S, Vong S, Toyoda T, Aubin JT, Miller M, Touch S,
Sovann L, Dufourcq JB, Richner B, et al.: Influenza A/H5N1 virus
infection in humans in Cambodia.  J Clin Virol 2007,
39(3):164-168.
12. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN,
Hoang DM, Chau NV, Khanh TH, Dong VC, et al.: Fatal outcome
of human influenza A (H5N1) is associated with high viral
load and hypercytokinemia.  Nat Med 2006, 12(10):1203-1207.
13. Gu J, Xie Z, Gao Z, Liu J, Korteweg C, Ye J, Lau LT, Lu J, Zhang B,
McNutt MA, et al.: H5N1 infection of the respiratory tract and
beyond: a molecular pathology study.  Lancet 2007,
370(9593):1137-1145.
14. de Jong MD, Bach VC, Phan TQ, Vo MH, Tran TT, Nguyen BH, Beld
M, Le TP, Truong HK, Nguyen VV, et al.: Fatal avian influenza A
(H5N1) in a child presenting with diarrhea followed by coma.
N Engl J Med 2005, 352(7):686-691.
15. Yao L, Korteweg C, Hsueh W, Gu J: Avian influenza receptor
expression in H5N1-infected and noninfected human tissues.
FASEB J 2008, 22(3):733-740.
16. Fuchs S, Hollins AJ, Laue M, Schaefer UF, Roemer K, Gumbleton M,
Lehr CM: Differentiation of human alveolar epithelial cells in
primary culture: morphological characterization and syn-
thesis of caveolin-1 and surfactant protein-C.  Cell Tissue Res
2003, 311(1):31-45.
17. Krunkosky TM, Fischer BM, Martin LD, Jones N, Akley NJ, Adler KB:
Effects of TNF-alpha on expression of ICAM-1 in human air-
way epithelial cells in vitro. Signaling pathways controlling
surface and geneexpression.  Am J Respir Cell Mol Biol 2000,
22(6):685-692.
18. Jurczyluk J, Brown D, Stanley KK: Polarised secretion of
cytokines in primary human microvascular endothelial cells
is not dependent on N-linked glycosylation.  Cell Biol Int 2003,
27(12):997-1003.
19. Nicholls JM, Bourne AJ, Chen H, Guan Y, Peiris JS: Sialic acid recep-
tor detection in the human respiratory tract: evidence for
widespread distribution of potential binding sites for human
and avian influenza viruses.  Respir Res 2007, 8:73.
20. Crapo JD, Barry BE, Gehr P, Bachofen M, Weibel ER: Cell number
and cell characteristics of the normal human lung.  Am Rev
Respir Dis 1982, 125(6):740-745.
21. Thompson CI, Barclay WS, Zambon MC, Pickles RJ: Infection of
human airway epithelium by human and avian strains of
influenza a virus.  J Virol 2006, 80(16):8060-8068.
22. Ebisawa IT, Kitamoto O, Takeuchi Y, Makino M: Immunocytologic
study of nasal epithelial cells in influenza.  Am Rev Respir Dis
1969, 99(4):507-515.
23. Tashiro M, Yamakawa M, Tobita K, Klenk HD, Rott R, Seto JT:
Organ tropism of Sendai virus in mice: proteolytic activation
of the fusion glycoprotein in mouse organs and budding site
at the bronchial epithelium.  J Virol 1990, 64(8):3627-3634.
24. Tashiro M, Yamakawa M, Tobita K, Seto JT, Klenk HD, Rott R:
Altered budding site of a pantropic mutant of Sendai virus,
F1-R, in polarized epithelial cells.  J Virol 1990,
64(10):4672-4677.
25. Roth MG, Srinivas RV, Compans RW: Basolateral maturation of
retroviruses in polarized epithelial cells.  J Virol 1983,
45(3):1065-1073.
26. Rossen JW, Horzinek MC, Rottier PJ: Coronavirus infection of
polarized epithelial cells.  Trends Microbiol 1995, 3(12):486-490.
27. Blau DM, Compans RW: Entry and release of measles virus are
polarized in epithelial cells.  Virology 1995, 210(1):91-99.
28. Roberts SR, Compans RW, Wertz GW: Respiratory syncytial
virus matures at the apical surfaces of polarized epithelial
cells.  J Virol 1995, 69(4):2667-2673.
29. Steinhauer DA: Role of hemagglutinin cleavage for the patho-
genicity of influenza virus.  Virology 1999, 258(1):1-20.
30. Yen HL, Aldridge JR, Boon AC, Ilyushina NA, Salomon R, Hulse-Post
DJ, Marjuki H, Franks J, Boltz DA, Bush D, et al.: Changes in H5N1
influenza virus hemagglutinin receptor binding domain
affect systemic spread.  Proc Natl Acad Sci USA 2009,
106(1):286-291.
31. Abdel-Ghafar AN, Chotpitayasunondh T, Gao Z, Hayden FG, Nguyen
DH, de Jong MD, Naghdaliyev A, Peiris JS, Shindo N, Soeroso S, et al.:
Update on avian influenza A (H5N1) virus infection in
humans.  N Engl J Med 2008, 358(3):261-273.
32. Adamson IY, Bowden DH: The type 2 cell as progenitor of alve-
olar epithelial regeneration. A cytodynamic study in mice
after exposure to oxygen.  Lab Invest 1974, 30(1):35-42.
33. Vracko R: Significance of basal lamina for regeneration of
injured lung.  Virchows Arch A Pathol Pathol Anat 1972,
355(3):264-274.
34. Kawanami O, Ferrans VJ, Crystal RG: Structure of alveolar epi-
thelial cells in patients with fibrotic lung disorders.  Lab Invest
1982, 46(1):39-53.
35. Ronni T, Matikainen S, Sareneva T, Melen K, Pirhonen J, Keskinen P,
Julkunen I: Regulation of IFN-alpha/beta, MxA, 2',5'-oligoade-
nylate synthetase, and HLA gene expression in influenza A-
infected human lung epithelial cells.  J Immunol 1997,
158(5):2363-2374.
36. Cheung CY, Poon LL, Lau AS, Luk W, Lau YL, Shortridge KF, Gordon
S, Guan Y, Peiris JS: Induction of proinflammatory cytokines in
human macrophages by influenza A (H5N1) viruses: a mech-
anism for the unusual severity of human disease?  Lancet 2002,
360(9348):1831-1837.
37. Peiris JS, Yu WC, Leung CW, Cheung CY, Ng WF, Nicholls JM, Ng
TK, Chan KH, Lai ST, Lim WL, et al.: Re-emergence of fatal
human influenza A subtype H5N1 disease.  Lancet 2004,
363(9409):617-619.
38. Teruya-Feldstein J, Jaffe ES, Burd PR, Kanegane H, Kingma DW, Wil-
son WH, Longo DL, Tosato G: The role of Mig, the monokine
induced by interferon-gamma, and IP-10, the interferon-
gamma-inducible protein-10, in tissue necrosis and vascular
damage associated with Epstein-Barr virus-positive lympho-
proliferative disease.  Blood 1997, 90(10):4099-4105.
39. Baggiolini M: Chemokines and leukocyte traffic.  Nature 1998,
392(6676):565-568.
40. Zlotnik A, Yoshie O: Chemokines: a new classification system
and their role in immunity.  Immunity 2000, 12(2):121-127.
41. Campanella GS, Grimm J, Manice LA, Colvin RA, Medoff BD, Wojtk-
iewicz GR, Weissleder R, Luster AD: Oligomerization of
CXCL10 Is Necessary for Endothelial Cell Presentation and
In Vivo Activity.  J Immunol 2006, 177(10):6991-6998.
42. Bussfeld D, Kaufmann A, Meyer RG, Gemsa D, Sprenger H: Differ-
ential mononuclear leukocyte attracting chemokine produc-
tion after stimulation with active and inactivated influenza A
virus.  Cell Immunol 1998, 186(1):1-7.
43. Taub DD, Lloyd AR, Conlon K, Wang JM, Ortaldo JR, Harada A, Mat-
sushima K, Kelvin DJ, Oppenheim JJ: Recombinant human inter-
feron-inducible protein 10 is a chemoattractant for human
monocytes and T lymphocytes and promotes T cell adhesion
to endothelial cells.  J Exp Med 1993, 177(6):1809-1814.
44. Chan PK: Outbreak of avian influenza A(H5N1) virus infection
in Hong Kong in 1997.  Clin Infect Dis 2002, 34(Suppl 2):S58-64.
45. To KF, Chan PK, Chan KF, Lee WK, Lam WY, Wong KF, Tang NL,
Tsang DN, Sung RY, Buckley TA, et al.: Pathology of fatal human
infection associated with avian influenza A H5N1 virus.  J Med
Virol 2001, 63(3):242-246.
46. Seo SH, Hoffmann E, Webster RG: Lethal H5N1 influenza viruses
escape host anti-viral cytokine responses.  Nat Med 2002,
8(9):950-954.
47. Mok CK, Lee DC, Cheung CY, Peiris M, Lau AS: Differential onset
of apoptosis in influenza A virus H5N1- and H1N1-infected
human blood macrophages.  J Gen Virol 2007, 88(Pt
4):1275-1280.
48. Korteweg C, Gu J: Pathology, molecular biology, and patho-
genesis of avian influenza A (H5N1) infection in humans.  Am
J Pathol 2008, 172(5):1155-1170.
49. Uiprasertkul M, Kitphati R, Puthavathana P, Kriwong R, Kongchanagul
A, Ungchusak K, Angkasekwinai S, Chokephaibulkit K, Srisook K, Van-
prapar N, et al.: Apoptosis and pathogenesis of avian influenza
A (H5N1) virus in humans.  Emerg Infect Dis 2007, 13(5):708-712.
50. Ng WF, To KF, Lam WW, Ng TK, Lee KC: The comparative
pathology of severe acute respiratory syndrome and avian
influenza A subtype H5N1--areview.  Hum Pathol 2006,
37(4):381-390.Page 12 of 12
(page number not for citation purposes)
